Apple Pulls Apple Watch Series 9 and Ultra 2 Ahead of Expected U.S. Ban Over Patent Dispute





If you want to buy an Apple Watch Series 9 or an Apple Watch Ultra 2 in the U.S., your days are numbered.

The tech giant said that the two smartwatch models will no longer be available to order online as of December 21 at 3 p.m. ET/6 p.m. PT, and Apple stores will no longer carry the models after December 24. You can also find these watches on Amazon HERE.

“A Presidential Review Period is in progress regarding an order from the U.S. International Trade Commission on a technical intellectual property dispute pertaining to Apple Watch devices containing the Blood Oxygen feature,” Apple said in a statement.

The news comes after the ITC ruled in October that Apple’s smartwatches infringed on patents owned by Masimo, a medical technology company. The company claims that Apple Watches violate its patents related to light-based technology for reading blood-oxygen levels.

During the 60-day review period, which ends on December 25, President Joe Biden could uphold or veto the ITC’s original ruling, but Apple said it’s “preemptively taking steps to comply” if the ruling is upheld.

“Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers,” Apple said in a statement.

It’s unclear at this time what this means for device support for current Watch Series 9 and Ultra 2 owners.

Disclaimer: To address the growing use of ad blockers we now use affiliate links to sites like, streaming services, and others. Affiliate links help sites like Cord Cutters News, stay open. Affiliate links cost you nothing but help me support my family. We do not allow paid reviews on this site. As an Amazon Associate I earn from qualifying purchases.

Subscribe to Our Newsletter

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.